The consumer discretionary sector continues to be in focus this week, not just as investor’s eye the group as potential winners of the “return to normal” trade, but also as they are the group that closes out Q4 earnings season.
Read More
As the worst of the severe winter weather is (hopefully) behind us at this point, and COVID cases improve nation-wide in conjunction with broader vaccine distribution and the addition of a third FDA approved vaccination from Johnson & Johnson...
Read More
Meme stocks are back in the news as high short-interest names feature elevated volatility. One such stock crossed our radar and is highlighted this week.
Read More
Impressive US retail sales provide further evidence of exceptional GDP growth in 2021.
Read More
Health-related stocks with unusual earnings dates are in focus
Read More
